UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Statin Toxicity

Circulation research, 2019-01, Vol.124 (2), p.328

2019

Link zum Volltext

Verfügbarkeit prüfen

Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

European heart journal, 2016-05, Vol.37 (17), p.1384-1394

2016

Link zum Volltext

Verfügbarkeit prüfen

Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production

Science (American Association for the Advancement of Science), 2010-01, Vol.327 (5965), p.580-583

2010

Link zum Volltext

Verfügbarkeit prüfen

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

The journal of clinical endocrinology and metabolism, 2012-11, Vol.97 (11), p.3956-3964

2012

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions

Nature communications, 2019-02, Vol.10 (1), p.687-687, Article 687

2019

Link zum Volltext

Verfügbarkeit prüfen

High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies

PLoS biology, 2020-09, Vol.18 (9), p.e3000870-e3000870

2020

Link zum Volltext

Verfügbarkeit prüfen

New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes

Clinical therapeutics, 2013-08, Vol.35 (8), p.1082-1098

2013

Link zum Volltext

Verfügbarkeit prüfen

Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial

The journal of clinical endocrinology and metabolism, 2015-08, Vol.100 (8), p.3140-3148

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)

The American journal of cardiology, 2017-01, Vol.119 (1), p.40-46

2017

Link zum Volltext

Verfügbarkeit prüfen

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033

2018

Link zum Volltext

Verfügbarkeit prüfen

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.1029-1039

2019

Link zum Volltext

Verfügbarkeit prüfen

Cadherin-11 in Synovial Lining Formation and Pathology in Arthritis

Science (American Association for the Advancement of Science), 2007-02, Vol.315 (5814), p.1006-1010

2007

Link zum Volltext

Verfügbarkeit prüfen

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Journal of the American College of Cardiology, 2014-06, Vol.63 (23), p.2541-2548

2014

Link zum Volltext

Verfügbarkeit prüfen

Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part

Atherosclerosis, 2018-10, Vol.277, p.399-406

2018

Link zum Volltext

Verfügbarkeit prüfen

New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease

Expert opinion on pharmacotherapy, 2014-03, Vol.15 (4), p.493-503

2014

Link zum Volltext

Verfügbarkeit prüfen

Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators

Immunity (Cambridge, Mass.), 2017-02, Vol.46 (2), p.220-232

2017

Link zum Volltext

Verfügbarkeit prüfen

Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry

Nature immunology, 2019-07, Vol.20 (7), p.928

2019

Link zum Volltext

Verfügbarkeit prüfen

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

European heart journal, 2011-06, Vol.32 (11), p.1345-1361

2011

Link zum Volltext

Verfügbarkeit prüfen

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

Circulation (New York, N.Y.), 2017-01, Vol.135 (4), p.338-351

2017

Link zum Volltext

Verfügbarkeit prüfen

Contemporary Aspects of the Biology and Therapeutic Regulation of the Microsomal Triglyceride Transfer Protein

Circulation research, 2015-01, Vol.116 (1), p.193-205

2015

Link zum Volltext

Verfügbarkeit prüfen

Familial hypercholesterolaemia in pregnancy: Australian case series and review

Australian & New Zealand journal of obstetrics & gynaecology, 2023-06, Vol.63 (3), p.402-408

2023

Link zum Volltext

Verfügbarkeit prüfen

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

International journal of cardiology, 2014-02, Vol.171 (3), p.309-325

2014

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in the management and implementation of care for familial hypercholesterolaemia

Pharmacological research, 2023-08, Vol.194, p.106857-106857, Article 106857

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 814

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(750)
Mit Volltextzugriff
(720)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(643)
Life Sciences & Biomedicine
(622)
Humans
(545)
Male
(250)
Cardiovascular System & Cardiology
(245)
Middle Aged
(210)
Female
(197)
Cardiac & Cardiovascular Systems
(179)
Adult
(174)
Cardiovascular Disease
(142)
Risk Factors
(135)
Biological And Medical Sciences
(127)
Peripheral Vascular Disease
(123)
Medical Sciences
(121)
Endocrinology & Metabolism
(117)
Aged
(104)
Cholesterol
(103)
Atherosclerosis
(78)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(77)
Lipids
(77)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Statin Toxicity

Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions

High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies

New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes

IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies

Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia

Cadherin-11 in Synovial Lining Formation and Pathology in Arthritis

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part

New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease

Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators

Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

Contemporary Aspects of the Biology and Therapeutic Regulation of the Microsomal Triglyceride Transfer Protein

Familial hypercholesterolaemia in pregnancy: Australian case series and review

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

Recent advances in the management and implementation of care for familial hypercholesterolaemia

Suchergebnisse filtern